Elevated endotoxin levels in non-alcoholic fatty liver disease. - Wikidata - awgldk - TriplyDB

Elevated endotoxin levels in non-alcoholic fatty liver disease.

Elevated endotoxin levels in non-alcoholic fatty liver disease.

http://www.wikidata.org/entity/Q33864406

about

Non-alcoholic fatty liver disease: what the clinician needs to know.Obesity, fatty liver disease and intestinal microbiota Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice Toll-like receptors in pathophysiology of liver diseases Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation The Curves Exercise Suppresses Endotoxemia in Korean Women with Obesity 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD).Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats.Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease Microbiome Remodeling via the Montmorillonite Adsorption-Excretion Axis Prevents Obesity-related Metabolic Disorders.Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity.Endotoxin levels correlate positively with a sedentary lifestyle and negatively with highly trained subjects Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease.Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study.Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis.Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death Microbiota and nonalcoholic steatohepatitis.The effect of berberis vulgaris extract on transaminase activities in non-alcoholic Fatty liver disease.Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.CD44 and HCELL: preventing hematogenous metastasis at step 1.A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet.Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease.Gut-liver axis, nutrition, and non-alcoholic fatty liver disease High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death.Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.Does lipopolysaccharide-mediated inflammation have a role in OA?Metabolic endotoxaemia in childhood obesity.Postprandial Effect of a High-Fat Meal on Endotoxemia in Arab Women with and without Insulin-Resistance-Related Diseases.Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.Toxins, Toxicity, and Endotoxemia: A Historical and Clinical Perspective for Chiropractors.

P2860

Q24563068-A9FB9F21-E403-4103-8459-6BCDDAFDE124 Q26997784-DACD239C-98F1-47AB-9938-848B3606D82C Q27330629-8154D94D-49AB-4172-A6E4-24B29B3DF696 Q27339224-650643FE-C4A6-455C-A43D-BF68F1330F94 Q28070077-DD805510-309C-4119-ABF9-CAC2AE9825DE Q28389532-C5DD22CF-05E5-49E3-9287-72196F797CBF Q30397027-9F340A19-09D7-4687-9B09-C9A1C10CFDB9 Q30412771-C8E415FD-6D4D-4974-98DF-5A2DDE51A5EE Q30452333-735A0CFA-21F1-4146-829B-78C649CA9F36 Q33650508-AE325FA5-9953-446D-89FE-4C11E04D9E48 Q33780172-F5C723DC-0F3E-4057-AD18-5A35A6D53165 Q33809487-BE7152AA-865C-4CB1-9ADD-2A4D5EEE5DAB Q33895584-FE7DB9A9-5A97-4530-AC38-8E514E0C371B Q34068261-7E8A0CB0-98F2-44B5-95F6-FA5A5992032A Q34171589-1F113A92-CCC8-427E-8122-BFFA1C153959 Q34330120-B06A196F-150D-49DA-9C9D-6806BF3E7591 Q34499067-8EC95880-3A32-4C1F-9967-4A0182BA3CC3 Q34589695-71EE5D1F-C2FF-4F18-A62C-883560CE9832 Q34641213-B3FE8A3A-449D-4894-9376-D9305689DDCE Q34702127-13888C17-A866-4716-871A-395B27EEE72E Q34704820-76230141-79C1-4B77-B89F-57B449C88AC3 Q34769697-950A0D06-5B13-4801-89E1-2649CF49B313 Q35061420-BD8CF02F-8D5D-4E71-A06E-9E3B524860CA Q35066721-FDE353F0-45EF-49DC-B02C-3A08D9070C30 Q35149311-1712EA4B-AC00-42DE-AA84-217518BB7AC0 Q35269130-AC688F6F-9F1E-4B81-91B4-265477A2CBBF Q35376738-462F6F1B-72DE-47B8-8CAA-4BB188A9A1C1 Q35515672-D5349317-D2E9-4046-AF3E-A9641BF4ABCF Q35591165-3A8EF0C4-D9D6-4E6A-9EE2-1ADB1F7372D9 Q35685083-C4025030-E809-4C94-A0E7-54D9CDCAB0BE Q35688347-0C712ACE-512E-44CC-B578-6D1073E555D6 Q35765830-6413AA16-C365-4F02-9480-9765363B4376 Q35858593-DFAACDEB-BA5F-4F0F-B213-C14DE6FDE5D0 Q35866185-E0FB0BBE-77AD-4E56-873A-453DB36F932D Q35906725-212F7657-CEE5-466A-9789-1B506EA2CFFE Q36012378-CD63D8B4-0B73-4C1E-85D5-D074433655BD Q36061317-99F1766E-FF5C-4E5E-8E2E-BFA152AE9750 Q36093199-B3DC6BF5-556A-4D60-BF7C-776331A47E52 Q36130937-C59143BE-7259-47C3-8C81-7223A51A7353 Q36213950-02C8E9A0-944B-47F6-BD3E-CF3001EBF1FA

P2860

Elevated endotoxin levels in non-alcoholic fatty liver disease.

http://www.wikidata.org/entity/Q33864406

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Elevated endotoxin levels in non-alcoholic fatty liver disease.

@ast

Elevated endotoxin levels in non-alcoholic fatty liver disease.

@en

type

label

Elevated endotoxin levels in non-alcoholic fatty liver disease.

@ast

Elevated endotoxin levels in non-alcoholic fatty liver disease.

@en

prefLabel

Elevated endotoxin levels in non-alcoholic fatty liver disease.

@ast

Elevated endotoxin levels in non-alcoholic fatty liver disease.

@en

P1433

Q33864406-77D2D2FC-B1C2-47E8-B0B4-DE089EDFD876

P1476

Q33864406-4C58B9F3-006D-4957-8474-EE0720C85483

P2093

Q33864406-24A3A6BD-DCA2-4353-9E20-FF812C26CA2E

Q33864406-27E0B447-3AFB-4FE9-8CDB-E7971D677EDE

Q33864406-2948F4C7-D76D-48AC-84B3-F0903931CED0

Q33864406-327F2181-1FD6-459A-A512-F4DC9A7E0ED7

Q33864406-5CD30A28-2C34-4544-82ED-3304870146D5

Q33864406-6F6E90FA-CAE4-4C21-951E-23C8E2CC08D0

Q33864406-7C162F89-77DA-400E-82CC-76FEC076B76E

Q33864406-9DCB0B6D-2A30-4472-828A-6BC7942DA507

Q33864406-C18617CC-0182-4A10-8C1D-438DF7A27217

Q33864406-E8E0DD84-7337-44D9-9F04-8B4BCF8B6B6E

P2860

Q33864406-00469B6F-BA8E-4A7F-A8F4-56B6BC6EFDD5

Q33864406-023D391A-1117-45B0-8DF8-87C86D902EE9

Q33864406-055023A3-7DA0-4E67-9812-7A13410BAF19

Q33864406-15377CCF-DFC3-48E7-B50F-0D5B483510D6

Q33864406-18AF3B30-EA59-42D4-A646-ACF46CCEF4C5

Q33864406-271C7D32-C551-471B-910E-63960703C3BA

Q33864406-27B42F36-E99F-4AF9-8184-B095417CB90A

Q33864406-45878115-5E8E-4FD6-860B-96C467F8EAE3

Q33864406-4A7A6FD0-1FB6-41B6-B834-AE42CF396A9E

Q33864406-5394BEF9-8EED-4F95-8E7C-AC4F7D75E2A1

P2888

Q33864406-A31722FC-4162-4680-97FC-D9D6E4F7C2E3

P304

Q33864406-E597D6CF-129C-4919-8C5B-9671BD97B2F4

P31

Q33864406-0E09FC5B-CCC4-4530-8074-4B5833FE7952

P356

Q33864406-2AE1B64E-BFFA-4823-9193-D7931F26D1F3

P478

Q33864406-1ECD36FE-FE6C-4757-AE3E-9A0ACD26D169

P50

Q33864406-0CF3C3C3-87AB-411A-B2BD-BC3E70DFB166

Q33864406-0E339679-749D-4742-B5DD-4E27D456303D

Q33864406-E235ABBF-BA99-4E00-A810-95139EA598BC

Q33864406-E8A1AAAD-AFF7-484D-B8F9-E67FDBC38195

P577

Q33864406-271EF46A-2F24-4036-B256-3D219F27C17F

P5875

Q33864406-A7401A0A-3930-43A3-9031-5B8983E9E876

P698

Q33864406-6EA328C7-D32A-4633-A587-586A552241F6

P921

Q33864406-DEA481D4-FF8F-4AE0-9037-E6880739DCA2

P932

Q33864406-629257F4-F231-491A-A897-EB16925E4C34

P356

P1433

Journal of Inflammation

P1476

Elevated endotoxin levels in non-alcoholic fatty liver disease.

@en

P2093

Alison L Harte

http://www.w3.org/2001/XMLSchema#string

Ashraf I Amin

http://www.w3.org/2001/XMLSchema#string

Christopher P Day

http://www.w3.org/2001/XMLSchema#string

Elham M Youssef-Elabd

http://www.w3.org/2001/XMLSchema#string

Gyanendra Tripathi

http://www.w3.org/2001/XMLSchema#string

Hayat M Sharada

http://www.w3.org/2001/XMLSchema#string

Kirsty C McGee

http://www.w3.org/2001/XMLSchema#string

Nancy F da Silva

http://www.w3.org/2001/XMLSchema#string

Philip G McTernan

http://www.w3.org/2001/XMLSchema#string

Steven J Creely

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor family and signalling pathway

Inflammation, stress, and diabetes

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

An obesity-associated gut microbiome with increased capacity for energy harvest

Microbial ecology: human gut microbes associated with obesity

Toll-like receptors as adjuvant receptors

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

Metabolic endotoxemia initiates obesity and insulin resistance

TLR4 enhances TGF-beta signaling and hepatic fibrosis

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

P2888

P304

15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-9255-7-15

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Alastair D. Burt

Mohga S Abdalla

P577

2010-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42767765

http://www.w3.org/2001/XMLSchema#string

P698

20353583

http://www.w3.org/2001/XMLSchema#string

P921

P932

2873499

http://www.w3.org/2001/XMLSchema#string